Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-27 @ 2:58 AM
Study NCT ID:
NCT04401293
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2020-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
Sponsor:
Northwell Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-20
First Submit QC Date:
None
Study First Post Date:
2020-05-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-29
Results First Submit QC Date:
None
Results First Post Date:
2021-11-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-17
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL